141 related articles for article (PubMed ID: 38440969)
1. Variability in expenses related to spine oncology care: comparison of payer-negotiated rates at National Cancer Institute-Designated Cancer Centers.
Kasthuri VS; Alsoof D; Balmaceno-Criss M; Daher M; McDonald CL; Diebo BG; Kuris EO; Daniels AH
Spine J; 2024 Feb; 24(2):304-309. PubMed ID: 38440969
[TBL] [Abstract][Full Text] [Related]
2. Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.
Burkhart RJ; Hecht CJ; Acuña AJ; Kamath AF
Clin Orthop Relat Res; 2022 Dec; 480(12):2316-2326. PubMed ID: 35901439
[TBL] [Abstract][Full Text] [Related]
3. The Price-Quality Mismatch: Are Negotiated Prices for Total Joint Arthroplasty Associated With Hospital Quality in a Large California Health System?
Zhuang T; Shapiro LM; Baker LC; Kamal RN
Clin Orthop Relat Res; 2023 Jun; 481(6):1061-1068. PubMed ID: 36729581
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Hospital Compliance With Federal Price Transparency Regulations and Variability of Negotiated Rates for Spinal Fusion.
Issa TZ; Lee Y; Mazmudar AS; Padovano R; Lambrechts MJ; Canseco JA; Hilibrand AS; Vaccaro AR; Kepler CK; Schroeder GD
J Am Acad Orthop Surg; 2023 Jul; 31(13):677-686. PubMed ID: 37015104
[TBL] [Abstract][Full Text] [Related]
5. Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance.
Xiao R; Ross JS; Gross CP; Dusetzina SB; McWilliams JM; Sethi RKV; Rathi VK
JAMA Intern Med; 2022 Jun; 182(6):603-611. PubMed ID: 35435948
[TBL] [Abstract][Full Text] [Related]
6. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
Sankaran R; O'Connor J; Nuliyalu U; Diaz A; Nathan H
Ann Surg Oncol; 2024 Mar; ():. PubMed ID: 38506934
[TBL] [Abstract][Full Text] [Related]
7. Private Payer-Negotiated Prices for Outpatient Otolaryngologic Surgery.
Wang AA; Xiao R; Sethi RKV; Rathi VK; Scangas GA
Otolaryngol Head Neck Surg; 2022 Aug; 167(2):262-265. PubMed ID: 34582305
[TBL] [Abstract][Full Text] [Related]
8. Compliance With Federal Price Transparency Rules and Cost Estimation at United States Hospitals With Neurosurgical Training Programs.
Giantini-Larsen A; Pandey A; Abou-Mrad Z; Tata N; Barzilai O; Bilsky M; Newman WC
Neurosurgery; 2024 Feb; ():. PubMed ID: 38345364
[TBL] [Abstract][Full Text] [Related]
9. Variations in Payer-Negotiated Prices for Head and Neck Reconstructive Surgery.
Wu SS; Rathi VK; Byrne PJ; Fritz MA; Shaye DA; Lee LN; Sethi RKV; Lindsay RW; Xiao R
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1154-1162. PubMed ID: 37337449
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy.
Agarwal A; Dayal A; Kircher SM; Chen RC; Royce TJ
JAMA Oncol; 2020 Mar; 6(3):409-412. PubMed ID: 31944219
[TBL] [Abstract][Full Text] [Related]
11. Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.
Gul ZG; Sharbaugh DR; Guercio CJ; Pelzman DL; Jones CA; Hacker EC; Anyaeche VI; Bowers L; Shah AM; Stencel MG; Yabes JG; Jacobs BL; Davies BJ
JAMA Netw Open; 2023 Jan; 6(1):e2249581. PubMed ID: 36602800
[TBL] [Abstract][Full Text] [Related]
12. Not Clearing the Air: Hospital Price Transparency for a Laparoscopic Cholecystectomy.
Green RL; Dunham P; Kling SM; Kuo LE
J Surg Res; 2022 Dec; 280():501-509. PubMed ID: 36081309
[TBL] [Abstract][Full Text] [Related]
13. Variation in Cost of Echocardiography Within and Across United States Hospitals.
Wei C; Milligan M; Lam M; Heidenreich PA; Sandhu A
J Am Soc Echocardiogr; 2023 Jun; 36(6):569-577.e4. PubMed ID: 36638930
[TBL] [Abstract][Full Text] [Related]
14. Outpatient apheresis billing: A photopheresis model shows that hospital price transparency data remain difficult to interpret.
Adkins BD; Booth GS; Jacobs JW; Jones H; Mouslim MC; Henderson MA
Am J Clin Pathol; 2023 Oct; 160(4):404-410. PubMed ID: 37265164
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.
Jiang JX; Polsky D; Littlejohn J; Wang Y; Zare H; Bai G
J Gen Intern Med; 2022 Nov; 37(14):3577-3584. PubMed ID: 34902095
[TBL] [Abstract][Full Text] [Related]
16. Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.
Horný M; Shafer PR; Dusetzina SB
JAMA Netw Open; 2021 Dec; 4(12):e2137390. PubMed ID: 34902037
[TBL] [Abstract][Full Text] [Related]
17. Physician Reimbursement in Medicare Advantage Compared With Traditional Medicare and Commercial Health Insurance.
Trish E; Ginsburg P; Gascue L; Joyce G
JAMA Intern Med; 2017 Sep; 177(9):1287-1295. PubMed ID: 28692718
[TBL] [Abstract][Full Text] [Related]
18. What Is the Value of Undergoing Surgery for Spinal Metastases at Dedicated Cancer Centers?
Malik AT; Khan SN; Voskuil RT; Alexander JH; Drain JP; Scharschmidt TJ
Clin Orthop Relat Res; 2021 Jun; 479(6):1311-1319. PubMed ID: 33543875
[TBL] [Abstract][Full Text] [Related]
19. Commercial Price Variation for Breast Reconstruction in the Era of Price Transparency.
Rochlin DH; Rizk NM; Matros E; Wagner TH; Sheckter CC
JAMA Surg; 2023 Feb; 158(2):152-160. PubMed ID: 36515928
[TBL] [Abstract][Full Text] [Related]
20. Negotiated Rates for Surgical Cancer Care in the Era of Price Transparency-Prices Reflect Market Competition.
Rochlin DH; Rizk NM; Matros E; Wagner TH; Sheckter CC
Ann Surg; 2024 Mar; 279(3):385-391. PubMed ID: 37678179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
